Takeda announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of Orzeyful (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with… read more.
Personal care products are among the largest everyday sources of exposure to endocrine-disrupting chemicals, and high schoolers who follow social media influencers or watch beauty tutorials seem to… read more.
Epilepsy remains a major public health challenge, but its burden is changing in ways that reveal health inequalities. Global Burden of Disease Study 2021 (GBD 2021) data indicate… read more.
Intensive, long-term blood pressure-lowering treatment reduced the risk of recurrent stroke by 38%, without increasing serious adverse events, in people who have survived an intracerebral haemorrhage (ICH). The… read more.
An international study has found that despite two decades of global tobacco control efforts, the message still is not getting through to enough smokers that smoking and second-hand… read more.
Lantheus Holdings, Inc. announced FDA approval of TAUKLARIFY (florquinitau F 18 injection), also referred to as MK 6240, a radiodiagnostic agent indicated for positron emission tomography (PET) of… read more.
Older adults with cardiovascular disease (CVD) often have coexisting cognitive impairment and frailty, conditions that can significantly affect treatment decisions, recovery, independence and quality of life and should… read more.
A study examined the brains of children at increased risk of developing schizophrenia to determine whether signs of vulnerability can be detected during childhood. The findings suggest that… read more.
Doctors may think they’re saying “Don’t panic.” But many patients hear “Don’t bother” instead. A new study from the University of California San Diego Rady School of Management… read more.
JCR Pharmaceuticals announced its development plan in Japan for givinostat, a treatment for Duchenne muscular dystrophy (DMD), following consultation with the Pharmaceuticals and Medical Devices Agency (PMDA). Based… read more.
Neck and back pain could be caused by changes in gene activity that trigger the breakdown of the spine’s natural shock absorbers, new research suggests. Findings from a… read more.
Having normal blood pressure, no diabetes and not smoking was associated with living nearly 13 years longer without dementia, according to a study published August 5, 2026, in Neurology® Open… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
